The global abdominal pain drugs market size was valued at USD 89.39 billion in 2024 and is expected to reach USD 131.06 billion by 2032, at a CAGR of 4.90% during the forecast period. The global business landscape is undergoing a transformation, with industries increasingly leaning on deep research and actionable insights to make strategic decisions. One segment...